00:00A breakthrough in cancer research.
00:03A Malaysian doctor has led a clinical trial in Chicago that could offer new hope for patients with advanced pancreatic
00:10cancer, one of the deadliest forms of the disease.
00:13Dr. M. Devalingam, who heads the study at Northwestern University, said the experimental treatment significantly improved survival outcomes in patients
00:23who typically live less than a year after diagnosis.
00:26The Phase 2 trial found that patients given LRAGlucib alongside standard chemotherapy were twice as likely to survive one year
00:35compared with those receiving chemotherapy alone.
00:38The treatment also reduced the risk of death by 38% in findings published in the journal Nature Medicine.
00:46Devalingam and his team are now preparing for a Phase 3 trial to confirm the results and move the treatment
00:51closer to wider use.
00:53Natasha Bust, FMT.
Comments